Pharmafile Logo

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Bedrock Healthcare Communications has produced a short film to raise awareness of rare diseases in recognition of Rare Disease Day 2022.

The film, ‘Noah’s Story’, highlights the fact that 1 in 20 people will be affected by a rare disease at some point in their life, and 75% of rare diseases affect children. Children like Noah – who had CLN2 Batten Disease. The film will premiere on Rare Disease Day, Monday February 28th. It’s 4 minutes of a true story you won’t want to miss.

- PMLiVE

Emily Wigginton, Bedrock’s Head of Client Services explained the inspiration behind the film… “In my curiosity to learn more about different rare diseases I found the website Noah’s Hope – Hope4Bridget and the story that the VanHoutan’s share about their family’s journey with CLN2 Batten Disease. It really moved me, and I felt compelled to use our voice on Rare Disease Day to help raise awareness, start conversations and help drive change. The VanHoutans and the families they put me in touch with are truly inspirational and I know how much it means to them that we shine a light on Batten Disease and help bring more awareness to the public about rare disease. I’m very grateful to them all for trusting us with their stories.”

Watch Noah’s Story at https://bedrock-health.com on Monday, 28th February.

This content was provided by Bedrock Healthcare Communications

Documents for download:

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.